Longqin Hu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Venues

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

ACS medicinal chemistry letters

Accounts of chemical research

Medicinal research reviews

Rutgers University Ernest Mario School of Pharmacy

University of Kansas (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rutgers University Ernest Mario School of Pharmacy

United States

Professor :: Medicinal Chemistry

Rutgers University Ernest Mario School of Pharmacy

United States

Associate Professor :: Medicinal Chemistry

Rutgers University Ernest Mario School of Pharmacy

United States

Assistant Professor :: Medicinal Chemistry

University of Oklahoma - College of Pharmacy

United States

Assistant Professor :: Medicinal Chemistry and Pharmaceutics

Education History

University of Kansas

United States

PHD :: Medicinal Chemistry

Second Military Medical University

China

MSC :: Medicinal Chemistry

Second Military Medical University

China

BSC :: Pharmacy

Publications

Longqin Hu, Haifa Albanyan, Jeffrey Yang, Yiling Wang, Min Yang, Xiangduan Tan, Xiaodi Zhong, Michael D Ward, Amrik Sahota
8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria. ACS medicinal chemistry letters 15 (7) (2024)
Longqin Hu, Haifa Albanyan, Jeffrey Yang, Yiling Wang, Min Yang, Xiangduan Tan, Xiaodi Zhong, Michael D Ward, Amrik Sahota
8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria. ACS medicinal chemistry letters 15 (7) (2024)
Jeffrey Yang, Haifa Albanyan, Yiling Wang, Yanhui Yang, Amrik Sahota, Longqin Hu
Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 32 (7) (2023)
Jun Wang, Daniel Lam, Jeffrey Yang, Longqin Hu
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (10) (2022)
Alexander G Shtukenberg, Longqin Hu, Amrik Sahota, Bart Kahr, Michael D Ward
Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention. Accounts of chemical research 55 (4) (2022)
Sumi Lee, Longqin Hu
Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 29 (5) (2020)
Subhadwip Basu, Jeffrey Yang, Bin Xu, Katarzyna Magiera-Mularz, Łukasz Skalniak, Bogdan Musielak, Vladyslav Kholodovych, Tad A Holak, Longqin Hu
Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction. Journal of medicinal chemistry 62 (15) (2019)
Jeffrey Yang, Longqin Hu
Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules. Medicinal research reviews 39 (1) (2018)

Longqin Hu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Longqin Hu